Brenig Preest
Biotechnology
CLC Bio
Belgium
Biography
Brenig Preest is a non-executive director of Apitope, appointed upon proposal of WSLF. Mr Preest is a founder and Investment Director of Arthurian Life Sciences Ltd, which manages WLSF and which was acquired by Arix Bioscience PLC in 2016. Mr Preest has over 23 years in the life science and finance sector, the majority of which has been in venture capital. He has led over 50 venture and growth capital investments and over the last 17 years has been a Board member of a number of public and private high growth companies. He has led the majority of investments from the WLSF. Mr Preest began his career at GE Healthcare, then PwC and Ernst and Young as a corporate financier. Mr Preest studied pharmacology at Cardiff University and Financial Strategy at Oxford Said, where he achieved a distinction. He is also a chartered accountant.
Research Interest
Biotechnology
